These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 1903580

  • 1. The acute effects of flecainide in the swine heart failing from incessant supraventricular tachycardia.
    Trippel DL, Harold ME, Spinale FG, Buckles DS, Gillette PC.
    Am Heart J; 1991 Jun; 121(6 Pt 1):1721-6. PubMed ID: 1903580
    [Abstract] [Full Text] [Related]

  • 2. Changes in left ventricular volume, mass, and function during the development and regression of supraventricular tachycardia-induced cardiomyopathy. Disparity between recovery of systolic versus diastolic function.
    Tomita M, Spinale FG, Crawford FA, Zile MR.
    Circulation; 1991 Feb; 83(2):635-44. PubMed ID: 1991381
    [Abstract] [Full Text] [Related]

  • 3. Tachycardia induced cardiomyopathy in dogs; relation between chronic supraventricular and chronic ventricular tachycardia.
    Zupan I, Rakovec P, Budihna N, Brecelj A, Kozelj M.
    Int J Cardiol; 1996 Sep; 56(1):75-81. PubMed ID: 8891808
    [Abstract] [Full Text] [Related]

  • 4. Direct effects of chronic beta-adrenergic receptor blockade on left ventricular and myocyte function in a model of tachycardia-induced congestive heart failure.
    Spinale FG, Johnson WS, Wang Y, Wang Z, Mukherjee R, Hebbar L, Jones BU.
    J Card Fail; 1996 Dec; 2(4):311-8. PubMed ID: 8989646
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ.
    Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396
    [Abstract] [Full Text] [Related]

  • 6. Acute blood pressure effects at the onset of supraventricular and ventricular tachycardia.
    Taneja T, Kadish AH, Parker MA, Goldberger JJ.
    Am J Cardiol; 2002 Dec 15; 90(12):1294-9. PubMed ID: 12480037
    [Abstract] [Full Text] [Related]

  • 7. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ.
    Am J Cardiol; 1988 Aug 25; 62(6):16D-22D. PubMed ID: 3136630
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH.
    Am J Cardiol; 1988 Aug 25; 62(6):44D-55D. PubMed ID: 3136636
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The hemodynamic effects of induced supraventricular tachycardia in man.
    Goldreyer BN, Kastor JA, Kershbaum KL.
    Circulation; 1976 Nov 25; 54(5):783-9. PubMed ID: 975474
    [Abstract] [Full Text] [Related]

  • 12. Effect of acute hemodynamic decompensation on electrical inducibility of ventricular arrhythmias in patients with dilated cardiomyopathy and complex nonsustained ventricular arrhythmias.
    Kulick DL, Bhandari AK, Hong R, Petersen R, Leon C, Rahimtoola SH.
    Am Heart J; 1990 Apr 25; 119(4):878-83. PubMed ID: 2321507
    [Abstract] [Full Text] [Related]

  • 13. Malignant arrhythmias and acute myocardial ischemia: interaction between flecainide and the autonomic nervous system.
    Stramba-Badiale M, Lazzarotti M, Facchini M, Schwartz PJ.
    Am Heart J; 1994 Nov 25; 128(5):973-82. PubMed ID: 7524295
    [Abstract] [Full Text] [Related]

  • 14. Effect of flecainide on atrial and ventricular refractoriness and conduction in patients with normal left ventricle. Implications for possible antiarrhythmic and proarrhythmic mechanisms.
    Katritsis D, Rowland E, O'Nunain S, Shakespeare CF, Poloniecki J, Camm AJ.
    Eur Heart J; 1995 Dec 25; 16(12):1930-5. PubMed ID: 8682029
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of flecainide in pacing-induced sustained ventricular tachyarrhythmias: correlation to clinical parameters and tachycardia-characteristics.
    Podczeck A, Borggrefe M, Bartels K, Breithardt G.
    Eur Heart J; 1989 Oct 25; 10(10):928-34. PubMed ID: 2513204
    [Abstract] [Full Text] [Related]

  • 16. Tachycardia-induced cardiomyopathy: effects on blood flow and capillary structure.
    Spinale FG, Zellner JL, Tomita M, Tempel GE, Crawford FA, Zile MR.
    Am J Physiol; 1991 Jul 25; 261(1 Pt 2):H140-8. PubMed ID: 1858914
    [Abstract] [Full Text] [Related]

  • 17. Relation between ventricular and myocyte remodeling with the development and regression of supraventricular tachycardia-induced cardiomyopathy.
    Spinale FG, Zellner JL, Tomita M, Crawford FA, Zile MR.
    Circ Res; 1991 Oct 25; 69(4):1058-67. PubMed ID: 1934334
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Collagen remodeling and changes in LV function during development and recovery from supraventricular tachycardia.
    Spinale FG, Tomita M, Zellner JL, Cook JC, Crawford FA, Zile MR.
    Am J Physiol; 1991 Aug 25; 261(2 Pt 2):H308-18. PubMed ID: 1877659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.